Featured episode
René Hoet | Taking risks and driving innovation in biopharma
Innovation in biopharma doesn’t happen by accident, it’s a compound effect of data discipline, cross-functional culture, and a willingness to take real technical risk.
In this premier episode of Models & Molecules, René Hoet traces what’s actually moved the needle in antibody discovery, from semi-synthetic phage libraries to the underused promise of phenotypic screening, and gives a sober perspective on where AI is making a difference today and where it still falls short.
About the podcast
At the intersection of computation and biology, Models & Molecules explores how data, algorithms, and science come together to design the medicines of tomorrow.
Each episode features candid conversations with the people shaping this transformation, from pharma R&D leaders to computational biologists and AI innovators, about the ideas, challenges, and technologies redefining how drugs are discovered.
Produced by ENPICOM, Models & Molecules offers a rare look behind the buzzwords of AI-driven discovery, uncovering the practical realities, lessons learned, and moments of insight that emerge when biology meets computation.